Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation

Acta Pharmacologica Sinica

Volumn 24, Issue 1, 2003, Pages 31-36

  Saeed, Sheikh Arshad ^a   Rasheed, Huma ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Diltiazem; Epinephrine; Platelet aggregation; Platelet activating factor; Verapamil; WEB 2086; Yohimbine

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADRENALIN; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; APAFANT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CHELERYTHRINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DILTIAZEM; ETODOLAC; FLURBIPROFEN; GENISTEIN; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PHOSPHOLIPASE C INHIBITOR; PIROXICAM; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST; VERAPAMIL; WORTMANNIN; YOHIMBINE;

ARTICLE; DEVICE; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; THROMBOCYTE AGGREGATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; AZEPINES; CALCIUM CHANNEL BLOCKERS; CYCLOOXYGENASE INHIBITORS; DRUG SYNERGISM; EPINEPHRINE; FLURBIPROFEN; HUMANS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; SIGNAL TRANSDUCTION; TRIAZOLES; VERAPAMIL; YOHIMBINE;

EID: 0037231078     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Heemskerk JWM, Sage O. Calcium signaling in platelets and other cells. Platelets 1994; 5: 295-316.
2. Hirafuji M, Shinoda H. Platelet-leukocyte interaction in adhesion to endothelial cells indiced by platelet activating factor in vitro. Br J Pharmacol 1991; 1356-77.
3. 2+ concentration and aggregation. J Pharmacol Exp Ther 1994; 271: 824-31.
4. Brass LF, Hoscie JA, Manning DR. Signaling through G proteins and G protein-coupled receptors during platelet activation. Thromb Haemost 1993; 70: 217-23.
5. Crabos M, Fabbro D, Stabel S, Erne P. Effect of tumour-promoting phorbol ester, thrombin platelets and regulation by calcium. Biochem J 1992; 288: 891-6.
6. Kimura Y, Okuda H. Effects of alpha- and beta-adrenergic antagonist on epinephrine-induced aggregation and intracellular free calcium concentration in human platelets. Biochem Biophys Res Commun 1994; 202: 1069-75.
7. Ware JA, Smith M, Salzman EW. Synergism of platelet aggregation: role of elevation of cytoplasmic calcium. J Ciln Invest 1987; 80: 267-71.
8. 2+ signaling pathways. Exp Mole Med 1999; 31: 42-6.
9. Sturk A, Asyee GM, Schaap MC, van Maanen M, ten Cate JW. Synergistic effects of platelet activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of cyclooxygenase pathway. Thrombo Res Suppl 1985; 40: 359-72.
10. Vargaftig BB, Fouque F, Benveniste J, Odiot J. Adrenaline and PAF-acether synergize to trigger cyclooxygenase-independent activation of plasma-free human platelets. Thrombo Res 1982; 28: 557-73.
11. Hourani SMO, Hall DA. Receptors for ADP on human blood platelets. Trends Pharmacol Sci 1994; 15: 103-8.
12. Piomelli D. Arachidonic acid in cell signaling. Curr opinion in cell Biol 1993; 5: 274-80.
13. Shah BH, Saeed SA. Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine. Res Comm Mol Pathol Pharmacol 1995; 89: 157-64.
14. Saeed SA, Simjee RU, Mehmood F, Rahman NN. Dual inhibition of platelet-activating factor and arachidonic acid metabolism by Ajmaline and effect on carrageenan-induced rat paw edema. J Pharm Pharmacol 1993, 45: 715-9.
15. Saeed SA, Gilani AH, Simjee R, Shah BH. Anti-thrombotic and anti-inflammatory effects of protopine. Pharmacol Res 1997; 36: 1-8.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75.
17. Banno Y, Asano T, Nozawa Y. Stimulation by G protein betagamma subunits of phospholipase C beta isoforms in human platelets. Thromb Haemost 1998; 79: 1008-3.
18. Berridge MJ. Inositol triphosphate and calcium signalling. Nature 1993; 361: 315-25.
19. Della Rocca GJ, Mausley S, Daaka Y, Lefkowitz RJ, Luttrell LM. Pleiotropic coupling of G protein-coupled receptors to the mitogen-activated protein kinase Cascade. Role of focal adhesions and receptor tyrosine kinases. J Biol Chem 1999; 274: 13978-84.
20. Masini E, Di Bello MG, Raspanti S, Fomusi NJ, Baronti R, Cappugi P, et al. The role of histamine in platelet aggregation by physiological and immunological stimuli. Inflamm Res 1998; 47: 211-20.
21. Offermanns S, Toombs CF, Hu YH, Simon M I. Defective platelet activation in Gq-deficient mice. Nature 1997; 389: 183-6.
22. Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 69: 58-178.
23. Leopoldt D, Harteneck C, Nurnberg B. G protein endogenously expressed in Sf 9 cells: interactions with mammalian histamine receptors. Naunyn Schmiedebergs Arch Pharmacol 1997; 356: 216-24.
24. Goodnight, SH. Aspirin therapy for cardiovascular diseases. Curr opin Hematol 1996; 3: 355-60.
25. Saeed SA, Afzal MN, Shah BH. Dual effect of Nimesulide, a COX-2 inhibitor in human platelet. Life Sci 1998; 63: 1835-41.
26. Frolich JC. A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes. Trends Pharmacol Sci 1997; 18: 30-4.
27. Randeau D, Percival MD, Boyee S, Brideau C, Charleson S, Cromlish W, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol 1997; 121: 105-17.
28. Shah BH, Lashari I, Rana S, Saeed O, Rasheed H, Saeed SA. Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of Phospholipase, MAP kinase and cyclooxygenase pathways. Pharmacol Res 2000; 42: 479-83.
29. Della Rocca GJ, Biesen TV, Daaka Y, Luttrell KD, Luttrell LM, Lefkowitz RJ. Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. J Biol Chem 1997; 272: 19125-32.
30. Borsh-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. J Biol Chem 1998; 273: 28766-72.
31. Pulcinelli FM, Ciampa MT, Favilla M, Pignatelli P, Riondino S, Gazzaniga PP. Concomitant activation of Gi protein-coupled receptor and protein kinase C or Phospholipase C is required for platelet aggregation. FEBS Lett 1998; 460: 37-40.